• 1. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 2. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 3. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 4. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 5. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzamides
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Benzamides

Professional Introduction to 2-Amino-3-fluorobenzamide (CAS No. 187805-54-5)

2-Amino-3-fluorobenzamide, with the chemical identifier CAS No. 187805-54-5, is a fluorinated benzamide derivative that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology. This compound represents a structurally intriguing molecule, featuring both an amino group and a fluorine substituent on a benzene ring, which together contribute to its unique physicochemical properties and biological activities. The presence of the fluorine atom, in particular, is well-documented to modulate the electronic and steric environment of the aromatic system, often enhancing binding affinity and metabolic stability—key attributes sought after in drug design.

The synthesis of 2-Amino-3-fluorobenzamide typically involves multi-step organic transformations, starting from commercially available precursors such as 3-fluorobenzoyl chloride or 3-fluorobenzoic acid. The introduction of the amino group is commonly achieved through nucleophilic aromatic substitution or amidation reactions, which require careful optimization to ensure high yield and purity. Advanced synthetic methodologies, including transition-metal-catalyzed cross-coupling reactions or microwave-assisted synthesis, have been explored to improve efficiency and scalability, aligning with modern pharmaceutical manufacturing standards.

Recent studies have highlighted the potential of 2-Amino-3-fluorobenzamide as a pharmacophore in the development of novel therapeutic agents. Its structural motif is reminiscent of known bioactive molecules, suggesting possible applications in targeting enzymes or receptors involved in critical biological pathways. For instance, fluorinated benzamides have been investigated for their role in modulating inflammatory responses, neurodegenerative diseases, and cancer progression. The electron-withdrawing effect of the fluorine atom can fine-tune the reactivity of the molecule, enabling selective interactions with biological targets.

In the realm of oncology research, 2-Amino-3-fluorobenzamide has been explored as a lead compound for designing kinase inhibitors. Kinases are pivotal enzymes in cellular signaling networks, and their dysregulation is often associated with tumor growth and metastasis. By leveraging computational modeling and high-throughput screening techniques, researchers have identified derivatives of this compound that exhibit promising inhibitory activity against specific kinases. Preliminary in vitro assays indicate that certain analogs can disrupt aberrant signaling cascades while maintaining selectivity over closely related enzymes.

The pharmacokinetic profile of 2-Amino-3-fluorobenzamide is another area of active investigation. The incorporation of a fluorine atom can influence metabolic stability, solubility, and distribution within biological systems. Studies employing molecular dynamics simulations have suggested that fluorine substitution enhances hydrophobicity, potentially improving membrane permeability but also necessitating careful consideration to avoid off-target effects. Understanding these relationships is crucial for optimizing drug candidates toward achieving desired therapeutic efficacy and minimal toxicity.

Furthermore, the versatility of 2-Amino-3-fluorobenzamide as a scaffold has led to its incorporation into libraries for fragment-based drug discovery programs. Fragment-based approaches rely on identifying small molecular fragments that bind weakly to targets but can be iteratively optimized into potent drugs. The structural features of this compound make it an attractive building block for generating diverse chemical space, facilitating the identification of novel lead structures with improved pharmacological properties.

The role of fluorinated aromatic compounds in medicinal chemistry cannot be overstated. The ability to fine-tune electronic properties through halogenation has been instrumental in developing drugs that exhibit enhanced binding affinities and reduced susceptibility to degradation by metabolic enzymes. 2-Amino-3-fluorobenzamide, as a representative example, underscores the importance of fluorine chemistry in modern drug design. Its continued study promises to yield insights into structure-activity relationships that could accelerate the development of next-generation therapeutics.

Future directions for research on 2-Amino-3-fluorobenzamide may include exploring its potential in combination therapies or investigating its effects on post-translational modifications such as phosphorylation or ubiquitination. Advances in proteomics and metabolomics are expected to provide deeper insights into how this compound interacts with biological systems at multiple levels. By integrating experimental data with computational predictions, scientists can refine molecular designs to maximize therapeutic outcomes while minimizing side effects.

In conclusion,2-Amino-3-fluorobenzamide (CAS No. 187805-54-5) stands as a testament to the innovative potential inherent in fluorinated benzamide derivatives. Its unique structural features offer opportunities for developing novel drugs across various therapeutic areas, particularly those involving enzyme inhibition or modulation of signaling pathways. As research progresses and new methodologies emerge,this compound will continue to serve as a valuable tool for medicinal chemists striving to address unmet medical needs through targeted molecular interventions.

• 63069-49-8(2-Amino-5-fluoro-benzamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)